[Conservative treatment of sub-clinical noninfiltrating cancers of the breast (102 EOA in situ, TONO)]
- PMID: 7741470
[Conservative treatment of sub-clinical noninfiltrating cancers of the breast (102 EOA in situ, TONO)]
Abstract
102 patients with sub-clinical intra ductal non invasive breast cancer (T0N0) treated by limited surgery and curative radiation therapy. Follow-up ranged from 2 to 10 years with a median follow-up of 59 months. The long term survival rate of this therapeutic approach, consisting of simple excision without any adjuvant treatment and radical mastectomy was close to 100%. The actuarial local recurrence rate was only 8.6% at 10 years (confidence interval: 4.6 to 12.6%), which strongly suggests that radiation therapy is active on multicentric foci. Salvage surgery could be performed in every case of local recurrence. The survival rate of in situ breast cancer (T0N0) treated by conservative radio-surgery is comparable to that of radical mastectomy, while cosmetic results and psychological impact appear to be better for the conservative technique (breast preservation rate = 91 to 96%).
Similar articles
-
Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history.Cancer J Sci Am. 1995 May-Jun;1(1):55-61. Cancer J Sci Am. 1995. PMID: 9166455
-
Conservative surgery and radiation therapy for intraductal carcinoma of the breast.J Fla Med Assoc. 1992 Nov;79(11):762-5. J Fla Med Assoc. 1992. PMID: 1336028 Review.
-
Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment.Breast Cancer Res Treat. 2006 Mar;96(1):47-51. doi: 10.1007/s10549-005-9033-7. Epub 2005 Oct 27. Breast Cancer Res Treat. 2006. PMID: 16261402
-
Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.Brachytherapy. 2008 Jan-Mar;7(1):29-36. doi: 10.1016/j.brachy.2007.12.001. Epub 2008 Jan 16. Brachytherapy. 2008. PMID: 18201940
-
Therapy of in situ cancer.Hematol Oncol Clin North Am. 1989 Dec;3(4):691-708. Hematol Oncol Clin North Am. 1989. PMID: 2558105 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical